Syneron Medical Ltd (ELOS) Tops Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million
February 15, 2017 7:01 AM ESTIRVINE, Calif., Feb. 15, 2017 /PRNewswire/ --
Total Revenue Grows 5.1% in 4Q16 and 7.3% for Full Year
Emerging Products¹ Revenue Grows 25.0% in 4Q16 and 42.1% for Full Year, Reaching $82.7 Million for Full Year
2016 GAAP net income per share of $0.01, up from net loss per share of $(0.17) in 2015; Non-GAAP net income per share increases from $0.18 to $0.35 for the year
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three and twelve month periods ended December 31,... More
